The metabotropic glutamate receptor subtype 5 antagonist MPEP and the Na+ channel blocker riluzole show different neuroprotective profiles in reversing behavioral deficits induced by excitotoxic prefrontal cortex lesions
- 31 December 2006
- journal article
- Published by Elsevier BV in Neuroscience
- Vol. 137 (1), 211-220
- https://doi.org/10.1016/j.neuroscience.2005.08.054
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Chronic But Not Acute Treatment with a Metabotropic Glutamate 5 Receptor Antagonist Reverses the Akinetic Deficits in a Rat Model of ParkinsonismJournal of Neuroscience, 2002
- Selective mGluR5 receptor antagonist or agonist provides neuroprotection in a rat model of focal cerebral ischemiaBrain Research, 2001
- Metabotropic Glutamate Receptor Subtypes as Targets for Neuroprotective DrugsJournal of Cerebral Blood Flow & Metabolism, 2001
- Selective Blockade of Type-1 Metabotropic Glutamate Receptors Induces Neuroprotection by Enhancing Gabaergic TransmissionMolecular and Cellular Neuroscience, 2001
- Selective blockade of metabotropic glutamate receptor subtype 5 is neuroprotectiveNeuropharmacology, 2000
- Expression and Signaling of Group I Metabotropic Glutamate Receptors in Astrocytes and MicrogliaJournal of Neurochemistry, 1999
- The Role of Excitotoxicity in Neurodegenerative DiseasePharmacology & Therapeutics, 1999
- Evidence for Functional Differences between Entopeduncular Nucleus and Substantia Nigra: Effects of APV (DL‐2‐amino‐5‐phosphonovaleric acid) Microinfusion on Reaction Time Performance in the RatEuropean Journal of Neuroscience, 1996
- Glutamate neurotoxicity and diseases of the nervous systemNeuron, 1988
- Depletion of dopamine in the caudate nucleus but not in nucleus accumbens impairs reaction-time performance in ratsJournal of Neuroscience, 1987